Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company ReViral Ltd.
DescriptionRSV fusion inhibitor
Molecular Target RSV F protein
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPreclinical
Standard IndicationRespiratory syncytial virus (RSV)
Indication DetailsTreat respiratory syncytial virus (RSV)
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today